WITHDRAWAL SYMPTOMS AS A PREDICTOR OF MORTALITY IN PATIENTS HIV-INFECTED THROUGH DRUG USE AND RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)
Uloženo v:
| Hlavní autor: | |
|---|---|
| Další autoři: | |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Témata: | |
| On-line přístup: | Path Enlace web pago |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky: WITHDRAWAL SYMPTOMS AS A PREDICTOR OF MORTALITY IN PATIENTS HIV-INFECTED THROUGH DRUG USE AND RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)
- USE OF ANTIRETROVIRAL THERAPIES BY HIV-INFECTED PERSONS RECEIVING METHADONE MAINTENANCE
- ACCES TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) FOR INJECTING DRUG USERS IN THE WHO EUROPEAN REGION 2002-2004
- "HAART": IMPACT OF MORTALITY, MORBIDITY PATTERNS AND SERVICE REQUIREMENTS FOR PEOPLE INFECTED WITH HIV
- Ongoing impact of HIV infection on mortality among people who inject drugs despite free antiretroviral therapy
- THE IMPACT OF METHADONE OR BUPRENORPHINE TREATMENT AND ONGOING INJECTION ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) ADHERENCE: EVIDENCE FROM THE MANIF2000 COHORT STUDY
- IMPACT OF HIV TESTING ON UPTAKE OF HIV THERAPY AMONG ANTIRETROVIRAL NAIVE HIV. INFECTED INJECTION DRUG USERS